Vistin Pharma ASA (FRA:VP4)

Market Cap	82.01M -6.2%
Revenue (ttm)	38.85M +6.7%
Net Income	6.66M +27.2%
EPS	0.15 +27.2%
Shares Out	n/a
PE Ratio	12.31
Forward PE	n/a
Dividend	0.11 (6.16%)
Ex-Dividend Date	Jun 4, 2025

Volume	n/a
Average Volume	n/a
Open	1.765
Previous Close	1.830
Day's Range	1.765 - 1.765
52-Week Range	1.710 - 2.100
Beta	n/a
RSI	46.15
Earnings Date	Feb 12, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1969
• Employees: 75
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: VP4

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial numbers in NOK